HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sinex Says 'Clear Your Head' To Launch Oral Dosage, Mist Sprays

This article was originally published in The Pink Sheet

Executive Summary

P&G will promote its re-launched Vicks Sinex nasal decongestant brand with an ad campaign that will feature the tagline, “The Clear Your Head Medicine.”

You may also be interested in...



Hispanic Consumers Make Large Target For OTC Brand Engagement – Survey

Half of US Hispanic consumers are seeking information on OTC products, say experts on Hispanic marketing during a CHPA webinar on the Hispanic path to purchase. Thirty-six percent of Hispanics glean data on OTCs from TV ads, compared to 19% of non-Hispanics.

P&G Sales Force Investment Delivers In Consumer Health Sales Growth

Selling the firm's brands to retailers requires knowledge of the products, but as recently as two years ago, the average tenure of salespersons in P&G's health care category's was less than 12 months, says CEO David Taylor.

Mucinex, Zyrtec Online Strategies Score While Most OTC Brands Miss

RB's Mucinex brand ranks highest among OTC drug brands evaluated in digital research firm L2’s Digital IQ Index, which found the OTC sector ranked last in digital ad spend among the top 10 industries. OTC product brands tend to be unsophisticated online and do not adequately link products to points of purchase.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS123123

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel